1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Nasopharyngeal Cancer Global Clinical Trials Review, H1, 2014

Nasopharyngeal Cancer Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Nasopharyngeal Cancer Global Clinical Trials Review, H1, 2014" provides data on the Nasopharyngeal Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Nasopharyngeal Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Nasopharyngeal Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Nasopharyngeal Cancer Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Nasopharyngeal Cancer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Nasopharyngeal Cancer to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Nasopharyngeal Cancer to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Nasopharyngeal Cancer 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Nasopharyngeal Cancer Therapeutics Clinical Trials 30
Prominent Drugs 32
Latest Clinical Trials News on Nasopharyngeal Cancer 33
Dec 16, 2011: Radiation Therapy Oncology Group Trial Results Show Bevacizumab Reduces Spread Of Nasopharyngeal Cancer 33
May 29, 2009: Cyclacel Reports Initial Phase 2 Seliciclib Data In Patients With Nasopharyngeal Carcinoma At 2009 Asco Annual Meeting 33
Mar 05, 2009: Cyclacel Announces Phase 1 Data Elucidating Pharmacodynamics and Mechanism Of Action Of Seliciclib In Nasopharyngeal Cancer 34
Aug 28, 2008: CYCLACEL Announces Recommendations Of Data Review Committee For Seliciclib Phase 2b Non-Small Cell Lung Cancer APPRAISE Trial 35
Jun 28, 2007: Cyclacel Pharmaceuticals Announces Results Of Phase II Seliciclib Combination Studies 35
Clinical Trial Profiles 37
Clinical Trial Overview of Top Companies 37
Sanofi 37
Clinical Trial Overview of Sanofi 37
F. Hoffmann-La Roche Ltd. 38
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 38
Merck and Co., Inc. 39
Clinical Trial Overview of Merck and Co., Inc. 39
Jiangsu Hengrui Medicine Co., Ltd. 40
Clinical Trial Overview of Jiangsu Hengrui Medicine Co., Ltd. 40
ZonMw 41
Clinical Trial Overview of ZonMw 41
Roche Hong Kong Limited 42
Clinical Trial Overview of Roche Hong Kong Limited 42
Lakewood-Amedex Inc. 43
Clinical Trial Overview of Lakewood-Amedex Inc. 43
C. H. Boehringer Sohn AG and Co. KG 44
Clinical Trial Overview of C. H. Boehringer Sohn AG and Co. KG 44
Biotech Pharmaceuticals Co., Ltd. 45
Clinical Trial Overview of Biotech Pharmaceuticals Co., Ltd. 45
Clinical Trial Overview of Top Institutes / Government 46
National Cancer Institute 46
Clinical Trial Overview of National Cancer Institute 46
Sun Yat-sen University 49
Clinical Trial Overview of Sun Yat-sen University 49
Sun Yat-Sen University Cancer Center 51
Clinical Trial Overview of Sun Yat-Sen University Cancer Center 51
Chinese University of Hong Kong 52
Clinical Trial Overview of Chinese University of Hong Kong 52
FUDAN University 53
Clinical Trial Overview of FUDAN University 53
Baylor College of Medicine 54
Clinical Trial Overview of Baylor College of Medicine 54
National University Hospital 55
Clinical Trial Overview of National University Hospital 55
European Organization for Research and Treatment of Cancer 56
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 56
The University of Hong Kong 57
Clinical Trial Overview of The University of Hong Kong 57
University of Washington 58
Clinical Trial Overview of University of Washington 58
Five Key Clinical Profiles 59
Appendix 78
Abbreviations 78
Definitions 78
Research Methodology 79
Secondary Research 79
About GlobalData 80
Contact Us 80
Disclaimer 80
Source 81

List of Tables
Nasopharyngeal Cancer Therapeutics, Global, Clinical Trials by Region, 2014* 7
Nasopharyngeal Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Nasopharyngeal Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Nasopharyngeal Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Nasopharyngeal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Nasopharyngeal Cancer Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Nasopharyngeal Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Nasopharyngeal Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Nasopharyngeal Cancer to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Nasopharyngeal Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Nasopharyngeal Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Nasopharyngeal Cancer to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Nasopharyngeal Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Nasopharyngeal Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Nasopharyngeal Cancer Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Nasopharyngeal Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Nasopharyngeal Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Nasopharyngeal Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Nasopharyngeal Cancer Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Nasopharyngeal Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Nasopharyngeal Cancer Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Nasopharyngeal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Nasopharyngeal Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Nasopharyngeal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Nasopharyngeal Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Nasopharyngeal Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
Nasopharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 37
Nasopharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 38
Nasopharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2014* 39
Nasopharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Jiangsu Hengrui Medicine Co., Ltd., 2014* 40
Nasopharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by ZonMw, 2014* 41
Nasopharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Roche Hong Kong Limited, 2014* 42
Nasopharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Lakewood-Amedex Inc., 2014* 43
Nasopharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG and Co. KG, 2014* 44
Nasopharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Biotech Pharmaceuticals Co., Ltd., 2014* 45
Nasopharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 46
Nasopharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2014* 49
Nasopharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-Sen University Cancer Center, 2014* 51
Nasopharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2014* 52
Nasopharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by FUDAN University, 2014* 53
Nasopharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2014* 54
Nasopharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National University Hospital, 2014* 55
Nasopharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2014* 56
Nasopharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Hong Kong, 2014* 57
Nasopharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014* 58

List of Figures
Nasopharyngeal Cancer Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Nasopharyngeal Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Nasopharyngeal Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Nasopharyngeal Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Nasopharyngeal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Nasopharyngeal Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Nasopharyngeal Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Proportion of Nasopharyngeal Cancer to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Nasopharyngeal Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Nasopharyngeal Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Nasopharyngeal Cancer to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Nasopharyngeal Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Nasopharyngeal Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Nasopharyngeal Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Nasopharyngeal Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Nasopharyngeal Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Nasopharyngeal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Nasopharyngeal Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Nasopharyngeal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Nasopharyngeal Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Nasopharyngeal Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
GlobalData Methodology 79

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.